Updates of the Belgian List of reimbursable devices in August 2025

In August 2025, the Belgian National Institute for Health and Disability Insurance (INAMI/RIZIV) updated the List of implants and invasive medical devices effective September 1, 2025. Key changes include:

• Introduction of a new sub-chapter “Bone conduction systems”, with three new material codes for the implantable part and six codes for the sound processor of an active transcutaneous bone conduction system, along with reimbursement tariffs and related conditions. The examples of newly added codes are 186513-186524 “Implantable part of an active transcutaneous bone conduction system with an electromagnetic transducer, including all fixation elements” and 186594-186605 “Sound processor of an active transcutaneous bone conduction system with an electromagnetic transducer, for beneficiaries from their eighth birthday”;
• Introduction of a new material code for bipolar radiofrequency endometrial ablation, with a corresponding reimbursement tariff and conditions.

Furthermore, Nominative lists were updated in August 2025. These lists specify certain brands in connection with material codes on the List of implants and invasive medical devices, when brand-specific registration is required. 

Two new Nominative lists were introduced, each registering one device: one for the implantable part and one for the sound processor of an active transcutaneous bone conduction system, linked to the newly added material codes. Changes will come into force on September 1, 2025. 

See full details in French here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.